GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » PT Bundamedik Tbk (ISX:BMHS) » Definitions » Gross Margin %

PT Bundamedik Tbk (ISX:BMHS) Gross Margin % : 47.03% (As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is PT Bundamedik Tbk Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. PT Bundamedik Tbk's Gross Profit for the three months ended in Mar. 2024 was Rp194,584 Mil. PT Bundamedik Tbk's Revenue for the three months ended in Mar. 2024 was Rp413,751 Mil. Therefore, PT Bundamedik Tbk's Gross Margin % for the quarter that ended in Mar. 2024 was 47.03%.


The historical rank and industry rank for PT Bundamedik Tbk's Gross Margin % or its related term are showing as below:

ISX:BMHS' s Gross Margin % Range Over the Past 10 Years
Min: 42.95   Med: 46.72   Max: 51.51
Current: 46.75


During the past 6 years, the highest Gross Margin % of PT Bundamedik Tbk was 51.51%. The lowest was 42.95%. And the median was 46.72%.

ISX:BMHS's Gross Margin % is ranked better than
57.14% of 609 companies
in the Healthcare Providers & Services industry
Industry Median: 41.74 vs ISX:BMHS: 46.75

PT Bundamedik Tbk had a gross margin of 47.03% for the quarter that ended in Mar. 2024 => Durable competitive advantage

The 5-Year average Growth Rate of Gross Margin for PT Bundamedik Tbk was 0.30% per year.


PT Bundamedik Tbk Gross Margin % Historical Data

The historical data trend for PT Bundamedik Tbk's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PT Bundamedik Tbk Gross Margin % Chart

PT Bundamedik Tbk Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross Margin %
Get a 7-Day Free Trial 47.38 42.95 51.51 46.09 46.76

PT Bundamedik Tbk Quarterly Data
Dec18 Dec19 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 47.06 45.68 46.98 47.16 47.03

Competitive Comparison of PT Bundamedik Tbk's Gross Margin %

For the Medical Care Facilities subindustry, PT Bundamedik Tbk's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PT Bundamedik Tbk's Gross Margin % Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, PT Bundamedik Tbk's Gross Margin % distribution charts can be found below:

* The bar in red indicates where PT Bundamedik Tbk's Gross Margin % falls into.



PT Bundamedik Tbk Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

PT Bundamedik Tbk's Gross Margin for the fiscal year that ended in Dec. 2023 is calculated as

Gross Margin % (A: Dec. 2023 )=Gross Profit (A: Dec. 2023 ) / Revenue (A: Dec. 2023 )
=695812.9 / 1488197.483
=(Revenue - Cost of Goods Sold) / Revenue
=(1488197.483 - 792384.606) / 1488197.483
=46.76 %

PT Bundamedik Tbk's Gross Margin for the quarter that ended in Mar. 2024 is calculated as


Gross Margin % (Q: Mar. 2024 )=Gross Profit (Q: Mar. 2024 ) / Revenue (Q: Mar. 2024 )
=194583.7 / 413751.175
=(Revenue - Cost of Goods Sold) / Revenue
=(413751.175 - 219167.444) / 413751.175
=47.03 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


PT Bundamedik Tbk  (ISX:BMHS) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

PT Bundamedik Tbk had a gross margin of 47.03% for the quarter that ended in Mar. 2024 => Durable competitive advantage


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


PT Bundamedik Tbk Gross Margin % Related Terms

Thank you for viewing the detailed overview of PT Bundamedik Tbk's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


PT Bundamedik Tbk (ISX:BMHS) Business Description

Traded in Other Exchanges
N/A
Address
Jl. Teuku Cik Ditiro No.28, Menteng, Jakarta Pusat, IDN, 10350
PT Bundamedik Tbk is a healthcare service provider. It offers maternal and child health services, outpatient services, inpatient services, emergency services, service excellence centers, IVF services, and Clinical laboratory services.

PT Bundamedik Tbk (ISX:BMHS) Headlines

No Headlines